Acquisitions - Schedule of Insignia Health, LLC and QueueDr purchase price consideration (Details) - USD ($) $ in Thousands |
Dec. 03, 2021 |
Jan. 08, 2021 |
|---|---|---|
| Insignia | ||
| Business Acquisition [Line Items] | ||
| Cash consideration paid on acquisition date | $ 37,112 | |
| Liabilities incurred | 96 | |
| Total fair value of acquisition consideration | $ 37,208 | |
| QueueDr | ||
| Business Acquisition [Line Items] | ||
| Cash consideration paid on acquisition date | $ 5,773 | |
| Liabilities incurred | 2,111 | |
| Contingent consideration | 2,240 | |
| Total fair value of acquisition consideration | $ 10,124 |
| X | ||||||||||
- Definition Business Combination, Consideration Transferred, Contingent Consideration No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|